Predicting timely transfer to adult care in a cohort of autistic adolescents and young adults.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 16 06 2023
accepted: 28 07 2023
medline: 15 9 2023
pubmed: 13 9 2023
entrez: 13 9 2023
Statut: epublish

Résumé

The transition from pediatric to adult care is a challenge for autistic adolescents and young adults. Data on patient features associated with timely transfer between pediatric and adult health care are limited. Our objective was to describe the patient features associated with timely transfer to adult health care (defined as </ = 6 months between first adult visit and most recent prior pediatric visit) among a cohort of autistic adolescents and young adults. We analyzed pediatric and adult electronic medical record data from a cohort of adolescents and young adults who established with a primary-care based program for autistic adolescents and young adults after they transferred from a single children's hospital. Using forward feature selection and logistic regression, we selected an optimal subset of patient characteristics or features via five repetitions of five-fold cross validation over varying time-frames prior to the first adult visit to identify patient features associated with a timely transfer to adult health care. A total of 224 autistic adolescents and young adults were included. Across all models, total outpatient encounters and total encounters, which are very correlated (r = 0.997), were selected as the first variable in 91.2% the models. These variables predicted timely transfer well, with an area under the receiver-operator curve ranging from 0.81 to 0.88. Total outpatient encounters and total encounters in pediatric care showed good ability to predict timely transfer to adult health care in a population of autistic adolescents and young adults.

Sections du résumé

BACKGROUND
The transition from pediatric to adult care is a challenge for autistic adolescents and young adults. Data on patient features associated with timely transfer between pediatric and adult health care are limited. Our objective was to describe the patient features associated with timely transfer to adult health care (defined as </ = 6 months between first adult visit and most recent prior pediatric visit) among a cohort of autistic adolescents and young adults.
METHODS AND FINDINGS
We analyzed pediatric and adult electronic medical record data from a cohort of adolescents and young adults who established with a primary-care based program for autistic adolescents and young adults after they transferred from a single children's hospital. Using forward feature selection and logistic regression, we selected an optimal subset of patient characteristics or features via five repetitions of five-fold cross validation over varying time-frames prior to the first adult visit to identify patient features associated with a timely transfer to adult health care. A total of 224 autistic adolescents and young adults were included. Across all models, total outpatient encounters and total encounters, which are very correlated (r = 0.997), were selected as the first variable in 91.2% the models. These variables predicted timely transfer well, with an area under the receiver-operator curve ranging from 0.81 to 0.88.
CONCLUSIONS
Total outpatient encounters and total encounters in pediatric care showed good ability to predict timely transfer to adult health care in a population of autistic adolescents and young adults.

Identifiants

pubmed: 37703269
doi: 10.1371/journal.pone.0289982
pii: PONE-D-23-18578
pmc: PMC10499209
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0289982

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002733
Pays : United States

Informations de copyright

Copyright: © 2023 Hart et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Pediatrics. 2012 Jun;129(6):1042-9
pubmed: 22585766
Pediatrics. 2018 Apr;141(Suppl 4):S318-S327
pubmed: 29610413
J Autism Dev Disord. 2018 Jan;48(1):36-44
pubmed: 28900771
Pediatrics. 2010 Apr;125(4):e748-54
pubmed: 20231189
Autism. 2017 Nov;21(8):972-984
pubmed: 27663266
Autism. 2015 Nov;19(8):992-1001
pubmed: 25504639
Ann Pharmacother. 2006 Jun;40(6):1086-95
pubmed: 16735648
Can J Psychiatry. 2012 Oct;57(10):601-7
pubmed: 23072951
J Pediatr Nurs. 2019 Sep - Oct;48:18-34
pubmed: 31220801
J Pediatr Nurs. 2015 Sep-Oct;30(5):714-23
pubmed: 26228309
J Adolesc Health. 2015 Jun;56(6):612-8
pubmed: 26003575
J Pediatr Rehabil Med. 2014;7(1):17-31
pubmed: 24919935
Autism. 2018 Jan;22(1):51-61
pubmed: 28750547
JAMA Pediatr. 2016 Mar;170(3):205-11
pubmed: 26619178
Inflamm Bowel Dis. 2015 Jul;21(7):1641-51
pubmed: 25966837
Pediatrics. 2018 Nov;142(5):
pubmed: 30348754
J Am Acad Child Adolesc Psychiatry. 2021 Jan;60(1):35-45
pubmed: 32387445
J Autism Dev Disord. 2022 Jul;52(7):2924-2933
pubmed: 34215949
J Gen Intern Med. 2013 Jun;28(6):761-9
pubmed: 23179969
J Autism Dev Disord. 2016 Apr;46(4):1441-54
pubmed: 26762115

Auteurs

Laura C Hart (LC)

Nationwide Children's Hospital, Columbus, OH, United States of America.
Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, United States of America.

Joseph Sirrianni (J)

Nationwide Children's Hospital, Columbus, OH, United States of America.

Steve Rust (S)

Nationwide Children's Hospital, Columbus, OH, United States of America.

Christopher Hanks (C)

Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH